Catalog |
name |
Description |
price |
R-M-5082 |
Dynamin inhibitory peptide,cas:251634-21-6 |
Dynamin inhibitory peptide is a peptide the GTPase dynamin; competitively blocks binding of dynamin to amphiphysin thus prevents endocytosis when administered intracellularly. Reduces GABAA receptor internalization and increases miniature ISPC amplitude and frequency in neurons expressing GABAA receptors. |
price> |
R-M-5083 |
Bax inhibitor peptide V5,cas:579492-81-2 |
Bax inhibitor peptide V5 is a cell-permeable synthetic peptide.Bax conformational change and mitochondrial translocation. Designed based on the Bax-binding domain of human Ku70. Inhibits Bax-mediated apoptosis in vitro. Shown to inhibit anti-cancer drug-induced apoptosis in vitro. |
price> |
R-M-5087 |
PKCε Inhibitor Peptide,Cas:182683-50-7 |
PKCɛ inhibitor peptide is a synthetic peptide corresponding to an amino acid sequence found in the amino terminal C2 domain of most mammalian forms of PKCɛ.It selectively and reversibly inhibits the translocation of PKCɛ to intracellular membranes, blocking activation. PKCɛ inhibitor peptide is commonly used in cells to evaluate the role of PKCɛ in various cellular responses.Protein kinase Cɛ (PKCɛ) is a calcium-independent, phospholipid- and diacylglycerol-dependent serine/threonine kinase involved in diverse signaling pathways, including those involved in neuronal signaling, cytoskeletal function, and inflammation. |
price> |
R-M-5088 |
PTD-p65-P1 Peptide TFA |
PTD-p65-P1 Peptide TFA is a nuclear transcription factor nf-kappab inhibitor, consisting of a membrane transport Peptide sequence derived from antennapedia linked to p65-p1, selectively inhibiting nf-kappab activity induced by various stimuli. |
price> |
R-M-5091 |
PKCα (C2-4) Inhibitor Peptide |
PKCα(C2-4) inhibitor peptide is a synthetic peptide that blocks PKC activity in HepG2 cells stimulated with calcium and pancreastatin when applied at 10 µM. |
price> |
R-M-5102 |
RNAIII-inhibiting peptide(TFA) |
RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus. RNAIII-inhibiting peptide (RIP) inhibits the synthesis of both RNAII and RNAIII, while RAP activates in wild type S. aureus cells. RNAIII-inhibiting peptide (5 μg/106 cells) potently reduces bacterial cell adhesion to HEp2 cells in the absence of serum, but with slight overall reduction the presence of serum. RNAIII-inhibiting peptide inhibits while RAP induces the phosphorylation of TRAP. |
price> |
R-M-5103 |
Macrophage Inhibitory Peptide |
Macrophage Inhibitory Peptide,a tripeptide of the second constant domain of human immunoglobulin G. |
price> |
R-M-5552 |
L-NIL,cas:150403-89-7 |
L-NIL (N6-(1-Iminoethyl)-lysine, hydrochloride) is a potent and selective inhibitor polypeptide of nitric oxide synthase that exhibits about 28-fold greater selectivity for inducible nitric oxide synthase (IC50 = 3.3 uM) than for the rat brain constitutive enzyme (IC50 = 92 uM). |
price> |